Since the announcement made Monday by the Pfizer and BioNTech laboratories of a vaccine against the Covid-19 “effective at 90%”, countries are starting to organize themselves to be sure to have priority access to treatment once it will be completely finalized. Canada announced on Tuesday that it had taken an option on 56 million additional doses of this future vaccine. These pre-orders are in addition to the 20 million doses already reserved by the government, confirmed a spokesperson for the Ministry of Public Services and Supply.
Canada has also signed agreements with the Americans Novavax, Johnson & Johnson and Moderna, as well as with the French Sanofi, the British GSK and the Swedish-British AstraZeneca. “Canada is one of the countries which has been able to conclude the most agreements and which has a portfolio of potential vaccines the most varied”, welcomed Prime Minister Justin Trudeau.
Europe in the ranks
For its part, the European Union announced on Tuesday that it was preparing to sign for 300 million doses of Pfizer’s new Covid-19 vaccine, three times more than the doses pre-ordered at this stage by the United States. .